Next Generation News and Research

RSS

Medical Vision launches the next generation of its Double Pump, with RF compatibility

Medical Vision AB today announced the launch of their new technology Double® Pump RF, an arthroscopy pump that adjusts flow and pressure automatically when a Shaver or an RF system is in use. Suction is simultaneously directed through the Shaver or RF handpiece to improve the functionality of these systems.

3 May 2012

Ben & Catherine Ivy Foundation to fund $45,000 pilot internship program at TGen

The Arizona-based Ben & Catherine Ivy Foundation will fund a $45,000 pilot internship program this summer and fall at the Translational Genomics Research Foundation (TGen).

3 May 2012

Xcellerex introduces XDUO Quad single-use mixing system for biomanufacturing

Xcellerex, Inc., a provider of turnkey biomanufacturing solutions, has launched its XDUO Quad single-use mixing system supporting single-use biomanufacturing in upstream and downstream mixing applications and unit operations.

3 May 2012

Genalyte to highlight Maverick Detection System at immunology conferences

Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced that it will launch an Early Access program for its Maverick™ Detection System and multiplexed autoimmune assays at two major immunology meetings in May.

2 May 2012

Topline, interim results from Celldex Phase 2b EMERGE study of CDX-011 for advanced breast cancer

Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell Medical College and the lead investigator of the EMERGE study, will join Celldex on the webcast to discuss data from the study.

2 May 2012

3M Health Care honored with Silver Edison Awards

Today, 3M Health Care announced it has been honored with a Silver Edison Award for Quality of Life in the Lifestyle and Social Impact category for its 3M™ Kind Removal Silicone Tape and a Silver Edison Award for Analytic Systems in the Science/Medical category for its Aerobic Procedure for Lactic Acid Bacteria with 3M Petrifilm Aerobic Count Plate. The Edison Awards, established in 1987, recognize the most innovative products in the world.

2 May 2012

Scientists are working out how sequencing the human genome can help treat disease

Though the human genome has been sequenced, scientists are still trying to figure out how the accomplishment can help people, for example, how it can be used to treat disease. As University of Massachusetts Amherst geneticist Jacob Mayfield notes, "It was easy to think of the human genome as the big prize, but what we realize now is, it's just a foot in the door."

2 May 2012

Krames StayWell releases new strategic growth platform for health care organizations

Krames StayWell, the leading health care communications and engagement company, in collaboration with Tea Leaves Health, has announced the release of Krames StayWell Engage 360 a breakthrough strategic growth platform for health care organizations.

2 May 2012

LifeCodexx completes PraenaTest clinical study on trisomy 21

LifeCodexx today announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing.

2 May 2012

CHR-3996 pill shows promise against advanced cancers

Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.

2 May 2012

Bruker first quarter revenue increases 13.6% to $405.6 million

Bruker Corporation today reported financial results for the first quarter ended March 31, 2012.

2 May 2012

Trovagene completes PCR assay development for detection of K-RAS mutations

Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced today that the Company has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers, and in 23% of all solid tumors.

30 Apr 2012

Hartford Foundation to honor five IU School of Medicine geriatricians

Five Indiana University School of Medicine geriatricians are among only 83 advanced fellows and junior faculty members nationwide who will share in $2.5 million in career development awards from The John A. Hartford Foundation.

30 Apr 2012

Detrimental effect of tetracycline on male reproductive function, sperm viability of pseudoscorpions

In a paper published today in Nature's open access journal Scientific Reports, researchers at the University of Nevada, Reno report that male pseudoscorpions treated with the antibiotic tetracycline suffer significantly reduced sperm viability and pass this toxic effect on to their untreated sons. They suggest that a similar effect could occur in humans and other species.

30 Apr 2012

Five U.S. federal agencies provide significant contributions each year to global health R&D

A new report that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world. That funding, according to the report, helped lead to the development of more than half of the 45 new health products in the last decade that have been used to save lives around the world.

30 Apr 2012

Cameron Health's subcutaneous ICD for sudden cardiac arrest receives FDA advisory panel approval

Cameron Health, Inc., a pioneer in the development, manufacture and distribution of next generation implantable cardioverter defibrillators (ICDs), announced today that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel voted 7-1 that sufficient data exists demonstrating the efficacy and safety of the S-ICD System for the treatment of sudden cardiac arrest (SCA).

27 Apr 2012

Allied Healthcare increases stake in Coridon to over 44%

Allied Healthcare Group (ASX: AHZ) announced today that post the recent capital raising it has invested a further $1 million into Coridon, increasing its holding in the company to 44.4%. Allied has increased its investment in Coridon as the Company progresses towards its Phase I study for a herpes vaccine and makes further progress on its HPV therapeutic vaccine program.

26 Apr 2012

Great Lakes NeuroTechnologies secures funding for development and testing of innovative neurotechnology

Great Lakes NeuroTechnologies Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson's Disease and Neuroscience Education April 24, 2012: Valley View, OH - Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health's SBIR program. Each project is focused on developing and testing innovative neurotechnology. Two projects focus on the monitoring and treatment of Parkinson's disease while another will develop a wireless physiological monitor and web-based teaching system for high school neuroscience courses.

26 Apr 2012

IMPAKT 2012 breast cancer conference to focus on four major areas

"Basic science and clinical medicine move at different pace because they follow different paths. Both however aim at improving strategies to manage cancer patients. We need to efficiently translate the good things from basic science and efficiently implement them in the clinic."

26 Apr 2012

Self-degradation response to antidepressant Zoloft observed in yeast cells

Princeton University researchers have observed a self-degradation response to the antidepressant Zoloft in yeast cells that could help provide new answers to lingering questions among scientists about how antidepressants work, as well as support the idea that depression is not solely linked to the neurotransmitter serotonin.

25 Apr 2012

Next Generation News and Research

Medical Vision launches the next generation of its Double Pump, with RF compatibility

Ben & Catherine Ivy Foundation to fund $45,000 pilot internship program at TGen

Xcellerex introduces XDUO Quad single-use mixing system for biomanufacturing

Genalyte to highlight Maverick Detection System at immunology conferences

Topline, interim results from Celldex Phase 2b EMERGE study of CDX-011 for advanced breast cancer

3M Health Care honored with Silver Edison Awards

Scientists are working out how sequencing the human genome can help treat disease

Krames StayWell releases new strategic growth platform for health care organizations

LifeCodexx completes PraenaTest clinical study on trisomy 21

CHR-3996 pill shows promise against advanced cancers

Bruker first quarter revenue increases 13.6% to $405.6 million

Trovagene completes PCR assay development for detection of K-RAS mutations

Hartford Foundation to honor five IU School of Medicine geriatricians

Detrimental effect of tetracycline on male reproductive function, sperm viability of pseudoscorpions

Five U.S. federal agencies provide significant contributions each year to global health R&D

Cameron Health's subcutaneous ICD for sudden cardiac arrest receives FDA advisory panel approval

Allied Healthcare increases stake in Coridon to over 44%

Great Lakes NeuroTechnologies secures funding for development and testing of innovative neurotechnology

IMPAKT 2012 breast cancer conference to focus on four major areas

Self-degradation response to antidepressant Zoloft observed in yeast cells

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News